National Register of Oesophageal Atresia
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 1,460
- Locations
- 74
- Primary Endpoint
- Number of esophageal atresia
Study Overview
Brief Summary
The esophageal atresia is a group of birth defects including a break in continuity of the esophagus with or without persistent communication with the trachea (tracheoesophageal fistula), sometimes associated (from 50%) of other malformations (heart, kidney, digestive ...).
The current prognosis for this ailment is good. However he persists a mortality (<10%) and significant morbidity, firstly related malformations (heart, kidney, for example), and secondly with particularly difficult anatomical forms (Forms long defect) .
The prevalence of this condition is estimated to be 1/2500 in 3000 live births, making an estimated ± 2,500 new cases over to 10 years in France.
The current project aims to set up a national registry (Metropolitan France and Dom Tom) to measure the prevalence of esophageal atresia among live births, phenotypic characteristics, the circumstances of their diagnosis, and their initial future at short-term during the first year of life, at which time occurs the vast majority of deaths and complications in this disease.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- — to 1 Year (Child)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •To be born in France
- •To have a esophageal atresia
Exclusion Criteria
- •To be born abroad
Arms & Interventions
Esophageal atresia
Intervention: data collection (Other)
Outcomes
Primary Outcomes
Number of esophageal atresia
Time Frame: 10 years
Secondary Outcomes
- Death(10 years)
- Data collection patient with esophageal atresia(10 years)
- Total number of patients with complications(10 years)